John W. McCauley

Identification of the glycosaminoglycan-binding site on the glycoprotein E(rns) of bovine viral diarrhoea virus by site-directed mutagenesis.

Inhibition of beta interferon transcription by noncytopathogenic bovine viral diarrhea virus is through an interferon regulatory factor 3-dependent mechanism.

Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission.

Differences in membrane association and sub-cellular distribution between NS2-3 and NS3 of bovine viral diarrhoea virus.

Role for bovine viral diarrhea virus Erns glycoprotein in the control of activation of beta interferon by double-stranded RNA.

Differential activation of interferon regulatory factors-3 and -7 by non-cytopathogenic and cytopathogenic bovine viral diarrhoea virus.

The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation.

Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virions.

Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses.

Within-host variation of avian influenza viruses.

The relationship between mutation frequency and replication strategy in positive-sense single-stranded RNA viruses.

Dynamics of influenza virus infection and pathology.

Intra- and interhost evolutionary dynamics of equine influenza virus.

Selection of variant viruses during replication and transmission of H7N1 viruses in chickens and turkeys.

Quantifying transmission of highly pathogenic and low pathogenicity H7N1 avian influenza in turkeys.

Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.

Receptor binding by a ferret-transmissible H5 avian influenza virus.

The influenza virus protein PB1-F2 interacts with IKKβ and modulates NF-κB signalling.

Receptor binding by an H7N9 influenza virus from humans.

Glyconanoparticles for the plasmonic detection and discrimination between human and avian influenza virus.

Infectivity and transmissibility of H9N2 avian influenza virus in chickens and wild terrestrial birds.

Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012.

Virus pathotype and deep sequencing of the HA gene of a low pathogenicity H7N1 avian influenza virus causing mortality in Turkeys.

Integrating influenza antigenic dynamics with molecular evolution.

A novel I221L substitution in neuraminidase confers high-level resistance to oseltamivir in influenza B viruses.

Receptor binding by H10 influenza viruses.

Enhanced human receptor binding by H5 haemagglutinins.

Infection and pathogenesis of canine, equine, and human influenza viruses in canine tracheas.

Receptor binding properties of the influenza virus hemagglutinin as a determinant of host range.

Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013.

The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.

Biophysical measurement of the balance of influenza a hemagglutinin and neuraminidase activities.

Focused antibody response to influenza linked to antigenic drift.

Global circulation patterns of seasonal influenza viruses vary with antigenic drift.

Optimization of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses.

Improving the representativeness of influenza viruses shared within the WHO Global Influenza Surveillance and Response System.

Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.

Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses.

Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones.

Role of the B Allele of Influenza A Virus Segment 8 in Setting Mammalian Host Range and Pathogenicity.